Bosnalijek is a Bosnian

pharmaceutical company The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate sympto ...

headquartered in

Sarajevo Sarajevo ( ; cyrl, Сарајево, ; ''see names in other languages'') is the capital and largest city of Bosnia and Herzegovina, with a population of 275,524 in its administrative limits. The Sarajevo metropolitan area including Sarajevo ...

Bosnia and Herzegovina Bosnia and Herzegovina ( sh, / , ), abbreviated BiH () or B&H, sometimes called Bosnia–Herzegovina and often known informally as Bosnia, is a country at the crossroads of south and southeast Europe, located in the Balkans. Bosnia and H ...

. Established in 1951, it is the largest pharmaceutical company in Bosnia and Herzegovina, present in more than 20 markets and having annual revenue of around 80 million euros (as of 2018).

History

Bosnalijek was established in 1951 in

FPR Yugoslavia The Socialist Federal Republic of Yugoslavia, commonly referred to as SFR Yugoslavia or simply as Yugoslavia, was a country in Central and Southeast Europe. It emerged in 1945, following World War II, and lasted until 1992, with the breakup of Yu ...

. In 2005,

International Finance Corporation The International Finance Corporation (IFC) is an international financial institution that offers investment, advisory, and asset-management services to encourage private-sector development in less developed countries. The IFC is a member of ...

provided Bosnalijek with a

€ The euro sign () is the currency sign used for the euro, the official currency of the eurozone and unilaterally adopted by Kosovo and Montenegro. The design was presented to the public by the European Commission on 12 December 1996. It consists ...

7.5 million loan for the construction of an €18.5 million production and distribution center. In August 2016, Bosnalijek celebrated its 65-year anniversary. In October 2016, the Government of Federation of Bosnia and Herzegovina sold its remaining shares in the company in the auction. As of 2019, Bosnalijek is presented in more than 20 markets, with revenues from foreign markets accounting for 76% of all revenues.

References

Pharmaceutical companies established in 1951 Companies based in Sarajevo Pharmaceutical companies of Bosnia and Herzegovina 1951 establishments in Yugoslavia Brands of Bosnia and Herzegovina {{Europe-company-stub